{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:23:22Z","timestamp":1784921002206,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Vicerrector\u00eda de Investigaci\u00f3n"},{"DOI":"10.13039\/501100005298","name":"University of Costa Rica","doi-asserted-by":"crossref","award":["VI-741-A9-513"],"award-info":[{"award-number":["VI-741-A9-513"]}],"id":[{"id":"10.13039\/501100005298","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ICGEB-CRP Program","award":["COS-08-03"],"award-info":[{"award-number":["COS-08-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.toxicon.2011.08.018","type":"journal-article","created":{"date-parts":[[2011,9,10]],"date-time":"2011-09-10T07:31:10Z","timestamp":1315639870000},"page":"558-564","source":"Crossref","is-referenced-by-count":50,"title":["Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom"],"prefix":"10.1016","volume":"58","author":[{"given":"Ileana","family":"M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yamileth","family":"Angulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J.","family":"Calvete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lomonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2011.08.018_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.toxicon.2009.10.024","article-title":"Pre-clinical and preliminary dose finding and safety studies to identify candidate antivenoms for treatment of envenoming by saw-scaled or carpet vipers (Echis ocellatus) in northern Nigeria","volume":"55","author":"Abubakar","year":"2010","journal-title":"Toxicon"},{"issue":"7","key":"10.1016\/j.toxicon.2011.08.018_bib2","doi-asserted-by":"crossref","first-page":"e767","DOI":"10.1371\/journal.pntd.0000767","article-title":"Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria","volume":"4","author":"Abubakar","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.toxicon.2011.08.018_bib3","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/S0006-2952(03)00579-3","article-title":"Inhibitory effect of fucoidan on the activities of crotaline snake venom myotoxic phospholipases A2","volume":"66","author":"Angulo","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxicon.2011.08.018_bib4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cbf.1208","article-title":"Differential susceptibility of C2C12 myoblasts and myotubes to group II phospholipase A2 myotoxins from crotalid snake venoms","volume":"23","author":"Angulo","year":"2005","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.toxicon.2011.08.018_bib5","first-page":"8","article-title":"Antivenomics of Atropoides mexicanus and Atropoides picadoi snake venoms: relationship to the neutralization of toxic and enzymatic activities","volume":"1","author":"Ant\u00fanez","year":"2010","journal-title":"J. Venom Res."},{"key":"10.1016\/j.toxicon.2011.08.018_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.toxicon.2007.10.008","article-title":"Ability of fucoidan to prevent muscle necrosis induced by snake venom myotoxins: comparison of high- and low-molecular weight fractions","volume":"51","author":"Azofeifa","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib7","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1749-6632.1994.tb26620.x","article-title":"Rattlesnake toxins alter development of muscle cells in culture","volume":"710","author":"Bieber","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"10.1016\/j.toxicon.2011.08.018_bib8","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/j.1471-4159.1993.tb03251.x","article-title":"Specific in\u00a0vitro biological activity of snake venom myotoxins","volume":"60","author":"Brus\u00e9s","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxicon.2011.08.018_bib9","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0167-4889(93)90080-9","article-title":"Effects on cultured mammalian cells of myotoxin III, a phospholipase A2 isolated from Bothrops asper (terciopelo) venom","volume":"1179","author":"Bultr\u00f3n","year":"1993","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2011.08.018_bib10","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.febslet.2009.03.029","article-title":"Venom, venomics, antivenomics","volume":"583","author":"Calvete","year":"2009","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2011.08.018_bib11","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4269\/ajtmh.2010.09-0733","article-title":"Antivenomic assessment of the immunological reactivity of EchiTAb-Plus-ICP, an antivenom for the treatment of snakebite envenoming in sub-Saharan Africa","volume":"82","author":"Calvete","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2011.08.018_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.toxicon.2009.01.011","article-title":"Paraspecific neutralization of the venom of African species of cobra by an equine antiserum against Naja melanoleuca: a comparative study","volume":"53","author":"Casasola","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib13","first-page":"515","article-title":"Snake-bites: appraisal of the global situation","volume":"76","author":"Chippaux","year":"1998","journal-title":"Bull. W.H.O."},{"key":"10.1016\/j.toxicon.2011.08.018_bib14","series-title":"Handbook of Venoms and Toxins of Reptiles","first-page":"453","article-title":"Snakebite in Africa. Current situation and urgent needs","author":"Chippaux","year":"2010"},{"key":"10.1016\/j.toxicon.2011.08.018_bib15","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4269\/ajtmh.2007.77.538","article-title":"Clinical trial of an F(ab\u2019)2 polyvalent equine antivenom for African snake bites in Benin","volume":"77","author":"Chippaux","year":"2007","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.toxicon.2011.08.018_bib16","doi-asserted-by":"crossref","first-page":"13289","DOI":"10.1016\/S0021-9258(18)51627-6","article-title":"Nigexine, a phospholipase A2 from cobra venom with cytotoxic properties not related to esterase activity","volume":"264","author":"Chwetzoff","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2011.08.018_bib17","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1007\/s00018-009-9053-2","article-title":"Calcium imaging of muscle cells treated with snake myotoxins reveals toxin synergism and presence of acceptors","volume":"66","author":"Cintra-Francischinelli","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.toxicon.2011.08.018_bib18","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/pr101091a","article-title":"Venomic and antivenomic analyses of the Central American coral snake, Micrurus nigrocinctus (Elapidae)","volume":"10","author":"Fern\u00e1ndez","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxicon.2011.08.018_bib19","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s00239-003-2461-2","article-title":"Molecular evolution and phylogeny of elapid snake venom three-finger toxins","volume":"57","author":"Fry","year":"2003","journal-title":"J. Mol. Evol."},{"key":"10.1016\/j.toxicon.2011.08.018_bib20","first-page":"2446","article-title":"Polyvalent horse F(ab\u2019)2 snake antivenom: development of process to produce polyvalent horse F(ab\u2019)2 antibodies anti-african snake venom","volume":"9","author":"Guidolin","year":"2010","journal-title":"Afr. J. Biotech."},{"key":"10.1016\/j.toxicon.2011.08.018_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/0041-0101(90)90110-S","article-title":"Standardization of assays for testing the neutralizing ability of antivenoms","volume":"28","author":"Guti\u00e9rrez","year":"1990","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.trstmh.2004.09.014","article-title":"Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa","volume":"99","author":"Guti\u00e9rrez","year":"2005","journal-title":"Trans. Royal Soc. Trop. Med. Hyg."},{"issue":"6","key":"10.1016\/j.toxicon.2011.08.018_bib23","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1371\/journal.pmed.0030150","article-title":"Confronting the neglected problem of snake bite envenoming: the need for a global partnership","volume":"3","author":"Guti\u00e9rrez","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.toxicon.2011.08.018_bib24","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.2174\/138161207782023784","article-title":"Trends in snakebite envenomation therapy: scientific, technological and public health considerations","volume":"13","author":"Guti\u00e9rrez","year":"2007","journal-title":"Curr. Pharm. Des"},{"key":"10.1016\/j.toxicon.2011.08.018_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jprot.2009.01.008","article-title":"Proteomic tools in the design and control of antivenoms for the treatment of snakebite envenomings","volume":"72","author":"Guti\u00e9rrez","year":"2009","journal-title":"J. Proteomics"},{"key":"10.1016\/j.toxicon.2011.08.018_bib26","series-title":"Handbook of Toxinology","first-page":"48","article-title":"Cytolytic toxins","author":"Harvey","year":"1990"},{"key":"10.1016\/j.toxicon.2011.08.018_bib27","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1432-1033.1987.tb11450.x","article-title":"Cobra cardiotoxins. Purification, effects on skeletal muscle and structure\/activity relationships","volume":"165","author":"Hodges","year":"1987","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.toxicon.2011.08.018_bib28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-4889(95)00053-U","article-title":"Effect of ammodytin L from Vipera ammodytes on L-6 cells from rat skeletal muscle","volume":"1268","author":"Incerpi","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.toxicon.2011.08.018_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.vascn.2010.09.001","article-title":"Validation of a cell-based assay to differentiate between the cytotoxic effects of elapid snake venoms","volume":"63","author":"Kalam","year":"2011","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"11","key":"10.1016\/j.toxicon.2011.08.018_bib30","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med."},{"key":"10.1016\/j.toxicon.2011.08.018_bib31","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0041-0101(03)00098-9","article-title":"A new Pan African polyspecific antivenom developed in response to the antivenom crisis in Africa","volume":"42","author":"Laing","year":"2003","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1042\/BJ20040354","article-title":"Proteomic characterization of two snake venoms: Naja naja atra and Agkistrodon halys","volume":"384","author":"Li","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2011.08.018_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0014-5793(99)00760-7","article-title":"Heparin binding to cobra basic phospholipase A2 depends on heparin chain length and amino acid specificity","volume":"453","author":"Lin","year":"1999","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2011.08.018_bib34","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/0041-0101(94)90408-1","article-title":"Broad cytolytic specificity of myotoxin II, a lysine-49 phospholipase A2 of Bothrops asper snake venom","volume":"32","author":"Lomonte","year":"1994","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib35","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0006-2952(94)90525-8","article-title":"Neutralization of the cytolytic and myotoxic activities of phospholipases A2 from Bothrops asper snake venom by glycosaminoglycans of the heparin\/heparan sulfate family","volume":"47","author":"Lomonte","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxicon.2011.08.018_bib36","doi-asserted-by":"crossref","first-page":"29867","DOI":"10.1016\/S0021-9258(18)43961-0","article-title":"Neutralizing interaction between heparins and myotoxin II, a Lys-49 phospholipase A2 from Bothrops asper snake venom. Identification of a heparin-binding and cytolytic toxin region by the use of synthetic peptides and molecular modeling","volume":"269","author":"Lomonte","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2011.08.018_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0041-0101(98)00171-8","article-title":"Comparative study of the cytolytic activity of myotoxic phospholipases A2 on mouse endothelial (tEnd) and skeletal muscle (C2C12) cells in\u00a0vitro","volume":"37","author":"Lomonte","year":"1999","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib38","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1021\/pr8000139","article-title":"Snake venomics and antivenomics of the arboreal neotropical pitvipers Bothriechis lateralis and Bothriechis schlegelii","volume":"7","author":"Lomonte","year":"2008","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxicon.2011.08.018_bib39","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.toxicon.2009.03.015","article-title":"Neutralization of Bothrops asper venom by antibodies, natural products and synthetic drugs: contributions to understanding snakebite envenomings and their treatment","volume":"54","author":"Lomonte","year":"2009","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib40","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0041-0101(93)90146-A","article-title":"Antagonism of the myotoxic effect of Bothrops jararacussu venom and bothropstoxin by polyanions","volume":"31","author":"Melo","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib41","doi-asserted-by":"crossref","first-page":"2838","DOI":"10.1002\/elps.200305552","article-title":"Proteomics of snake venoms from Elapidae and Viperidae families by multidimensional chromatographic methods","volume":"24","author":"Nawarak","year":"2003","journal-title":"Electrophoresis"},{"key":"10.1016\/j.toxicon.2011.08.018_bib42","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1002\/pmic.200700668","article-title":"Proteomic analysis of the venom from the fish eating coral snake Micrurus surinamensis: novel toxins, their functions and phylogeny","volume":"8","author":"Olamendi-Portugal","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.toxicon.2011.08.018_bib43","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0041-0101(93)90376-T","article-title":"Cardiotoxin 1 from cobra (Naja naja atra) venom causes necrosis of seletal muscle in\u00a0vivo","volume":"31","author":"Ownby","year":"1993","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib44","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1074\/jbc.272.3.1484","article-title":"Heparin and heparan sulfate bind to snake cardiotoxin","volume":"272","author":"Patel","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2011.08.018_bib45","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/pr101040f","article-title":"Snake venomics of African spitting cobras: toxin composition and assessment of congeneric cross-reactivity of the Pan-African EchiTAb-Plus-ICP antivenom by antivenomics and neutralization approaches","volume":"10","author":"Petras","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.toxicon.2011.08.018_bib46","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.toxicon.2008.09.002","article-title":"Characterization of a new polyvalent antivenom (Antivipmyn-Africa) against African vipers and elapids","volume":"52","author":"Ramos-Cerrillo","year":"2008","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib47","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1073\/pnas.84.10.3132","article-title":"Crystal structure of a snake venom cardiotoxin","volume":"84","author":"Rees","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.toxicon.2011.08.018_bib48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.toxicon.2009.08.010","article-title":"Preclinical assessment of the efficacy of a new antivenom (EchiTAb-Plus-ICP) for the treatment of viper envenoming in sub-Saharan Africa","volume":"55","author":"Segura","year":"2010","journal-title":"Toxicon"},{"key":"10.1016\/j.toxicon.2011.08.018_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nbt0207-173","article-title":"Bringing antivenoms to sub-Saharan Africa","volume":"25","author":"Stock","year":"2007","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.toxicon.2011.08.018_bib50","first-page":"949","article-title":"Development of simple standard assay procedures for the characterization of snake venoms","volume":"61","author":"Theakston","year":"1983","journal-title":"Bull. W.H.O."},{"key":"10.1016\/j.toxicon.2011.08.018_bib51","doi-asserted-by":"crossref","first-page":"9661","DOI":"10.1074\/jbc.272.15.9661","article-title":"Analysis of binding of cobra cardiotoxins to heparin reveals a new \u03b2-sheet heparin-binding structural motif","volume":"272","author":"Vyas","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.toxicon.2011.08.018_bib52","series-title":"Handbook of Clinical Toxicology of Animal Venoms and Toxins","first-page":"433","article-title":"Clinical toxicology of snakebite in Africa and the Middle East\/Arabian peninsula","author":"Warrell","year":"1995"},{"key":"10.1016\/j.toxicon.2011.08.018_bib53","series-title":"Envenomings and Their Treatments","first-page":"63","article-title":"Clinical features of envenoming from snake bites","author":"Warrell","year":"1996"},{"key":"10.1016\/j.toxicon.2011.08.018_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0140-6736(09)61754-2","article-title":"Snake bite","volume":"375","author":"Warrell","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.toxicon.2011.08.018_bib55","volume":"vol. 58","author":"World Health Organization","year":"1981"},{"key":"10.1016\/j.toxicon.2011.08.018_bib56","series-title":"Guidelines for the Prevention and Clinical Management of Snakebite in Africa","author":"World Health Organization","year":"2010"},{"key":"10.1016\/j.toxicon.2011.08.018_bib57","series-title":"WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins","author":"World Health Organization","year":"2010"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010111002741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010111002741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T05:32:00Z","timestamp":1638595920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010111002741"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":57,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0041010111002741"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2011.08.018","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}